01Mar 2021
ST2 is a biomarker of pediatric pulmonary arterial hypertension severity and clinical worsening.

ST2 is a biomarker of pediatric pulmonary arterial hypertension severity and clinical worsening.

Pediatric pulmonary hypertension (PH) is a severe disease defined by sustained elevation of pulmonary artery pressures, and pulmonary vascular resistance (PVR). Noninvasive diagnostic and prognostic markers that are more pulmonary vascular specific have been elusive because of disease heterogeneity and patient growth.

  • #pulmonology

Like

Save

Share